5 Einträge gefunden

1. Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

   1. Weisel, Katja
   2. Martin, Thomas
   3. Krishnan, Amrita
   4. Jagannath, Sundar
   5. Londhe, Anil
   6. Nair, Sandhya
   7. Diels, Joris

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma

   1. Costa, Luciano J
   2. Hari, Parameswaran
   3. Berdeja, Jesus G
   4. De Stefano, Valerio
   5. Gay, Francesca
   6. Hooper, Becky
   7. Bartlett, Meaghan

   2022 - Forschungsinformationssystem des UKE
3. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE-1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma

   1. Martin, Thomas
   2. Krishnan, Amrita
   3. Yong, Kwee
   4. Weisel, Katja
   5. Mehra, Maneesha
   6. Nair, Sandhya
   7. Qi, Keqin

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes

   1. Leleu, Xavier
   2. Martin, Thomas
   3. Weisel, Katja
   4. Schjesvold, Fredrik
   5. Iida, Shinsuke
   6. Malavasi, Fabio
   7. Manier, Salomon

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

   1. Moreau, Philippe
   2. Kumar, Shaji K
   3. San Miguel, Jesús
   4. Davies, Faith
   5. Zamagni, Elena
   6. Bahlis, Nizar
   7. Ludwig, Heinz

   2021 - Forschungsinformationssystem des UKE